National and Kapodistrian University of Athens
Ο ρόλος των CB1 υποδοχέων των κανναβινοειδών στις νευροβιολογικές δράσεις εξαρτησιογόνων φαρμάκων
Abstract
dc:descriptionObjective: To investigate the role of the CB1 cannabinoid receptor in the neurobiological mechanisms of drug dependence. Specifically, this study explored dopaminergic activity in discrete reward-related regions of the rat brain following administration of the cannabinoid CB1 agonists, Δ9-THC and WIN 55,212-2 as well as the effects of coadministration of WIN 55,212-2 and the CB1 antagonist, SR141716A on in vivo extracellular dopamine concentrations. In addition, the dopaminergic profile of WIN 55,212-2- and cocaine-administered rats subjected to the conditioned place preference (CPP) procedure was also examined as well as the effects of coadministration of either WIN 55,212-2 or SR141716A with the psychostimulant amphetamine on extracellular dopamine concentrations. In order to further investigate the impact of individual differences, two different rat phenotypes, high and low responders (HR and LR, respectively), differentiated according to their locomotor response upon exposure to a novel environment, were used throughout the study. Methods: Prior to the implementation of all experiments, rats were differentiated as HR or LR according to their initial locomotor response to an open field apparatus. Neurochemical measurements were performed in specific brain regions (dorsal striatum, nucleus accumbens, prefrontal cortex and amygdala) using High Performacne Liquid Chromatography with electrochemical detection (HPLC-ED) with the aim of constructing a neurochemical profile of dopaminergic activity for the cannabinoid agoinsts, Δ9-THC and WIN 55,212-2. Both high and low doses were used as representative of their observed biphasic behavioural profile. In addition, possible neurochemical differences between the two rat phenotypes were examined. Subsequently, in vivo effects of the synthetic cannabinoid agonist, WIN 55,212-2, on extracellular dopamine release in specific brain regions related to reward and addiction were studied using the in vivo microdialysis technique. Next, the ability of the selective CB1 antagonist/partial agonist, SR141716A, to modulate the effects of WIN 55,212-2 on extracellular dopamine levels was explored as well using microdialysis. Following this study, the reinforcing properties of WIN 55,212-2 were compared against the psychostimulant, cocaine, as assessed at the behavioural level using the CPP procedure and furthermore, at the neurochemical level, by measuring tissue levels of dopamine and its metabolites with HPCL-ED. Lastly, the in vivo effects of coadministration of the psychostimulant, d-amphetamine, with either WIN 55,212-2 or SR141716A on extracellular dopamine levels were also assessed with microdialysis. ............................................................
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Polissidis, Alexia-Victoria
- Πολυσίδη, Αλεξία-Βικτώρια
Subjects
dc:subject × 20- Κανναβινοειδή
- Ντοπαμίνη
- Πειραματόζωα
- Νευροχημεία
- Εξαρτησιογόνα φάρμακα
- In vivo μικροδιάλυση
- Εξαρτημένη συμπεριφορά προτίμηση θέσης
- CB1 υποδοχέας κανναβινοειδών
- Cannabinoids
- Dopamine
- Rats
- Neurochemistry
- Drugs of abuse
- In vivo microdialysis
- Conditioned place prefence
- CB1 receptor
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/23979